Sharda Cropchem Limited — Investor Meet, 03-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Sharda Cropchem delivered robust Q3 FY26 results with revenue up 39% to INR 1,289 Cr and PAT up 366% to INR 145 Cr, driven by 14% volume growth. Gross margins expanded to 34.9% and EBITDA margins to 19.1%. For 9M FY26, the company achieved its highest-ever annual PAT. Management expects strong momentum in Q4 FY26 and FY27, guiding for 15-20% revenue growth and 18-20% EBITDA margins. Europe showed strong demand-driven growth. The company maintains a net debt-free position with INR 826 Cr cash, and declared an INR 6/share interim dividend, looking to increase payouts. Global agrochem market is recovering with normalizing inventories and rising prices.